Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
80,746
-
Shares change
-
-101,556
-
Total reported value, excl. options
-
$45,311
-
Value change
-
-$111,441
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$0.561
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q3 2024
15 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q3 2024.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80,746 shares
.
Largest 10 shareholders include SUSQUEHANNA INTERNATIONAL GROUP, LLP (18,223 shares), GEODE CAPITAL MANAGEMENT, LLC (17,751 shares), TWO SIGMA SECURITIES, LLC (14,242 shares), UBS Group AG (12,762 shares), VANGUARD GROUP INC (12,598 shares), Tower Research Capital LLC (TRC) (4,792 shares), CoreCap Advisors, LLC (200 shares), OSAIC HOLDINGS, INC. (80 shares), Federation des caisses Desjardins du Quebec (32 shares), and American Capital Advisory, LLC (31 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.